More on SGEN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (3.0 Score)
- Holders
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- M&A (3/31/18 *Est)
- M&A (12/31/23 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

SGEN Balance Sheet

Click line-items for a historical chart and %
Cash and cash equivalents 131.03M
Short-term investments
Interest receivable
Accounts receivable 65.12M
Prepaid expenses and other current assets 15.74M
Total current assets 744.3M
Property and equipment, net 54.72M
Long-term investments
Other non-current assets
Total assets 849.91M
Accounts payable and accrued liabilities
Current portion of deferred revenue 30.49M
Total current liabilities 125.81M
Deferred revenue, less current portion 59M
Deferred rent and other long-term liabilities 2.81M
Total long-term liabilities 61.81M
Commitments and contingencies 0
Preferred stock, $0.001 par value, 5,000 shares authorized; none issued and outstanding 0
Common stock, $0.001 par value, 250,000 shares authorized at June 30, 2011 and 150,000 shares authorized at December 31, 2010; 114,419 shares issued and outstanding at June 30, 2011 and 101,607 shares issued and outstanding at December 31, 2010 142K
Additional paid-in capital 1.67B
Accumulated other comprehensive loss 215K
Accumulated deficit -1.01B
Total stockholders' equity 662.29M
Total liabilities and stockholders' equity 849.91M